Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 2 minute read Pharma Industry News 4D Molecular Therapeutics secures $90m in Series B to advance gene therapy innovations California-based 4D Molecular Therapeutics (4DMT), specializing in adeno-associated virus (AAV) gene therapy vector discovery and product development, has… bypharmanewsdailySeptember 6, 2018
